Derma-Study-Center Friedrichshafen GmbH

Friedrichshafen, Baden-Wurttemberg 88045

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1) — Completed
• Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis — Completed